Evidence map›Paper›PMID 42290712›Full record

ArticleFrontiers in pediatrics2026

Case Report: Lymphatic malformation in a paediatric patient with a 7-year follow-Up.

Luyao Wang, Lei Guo

Erratum issuedAbstract readCase Reports
In one paragraph

Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Luyao WangDepartment of Intervention and Hemangioma, Children's Hospital Affiliated to Shandong University, Jinan, Shandong Province, China.
Lei GuoDepartment of Intervention and Hemangioma, Children's Hospital Affiliated to Shandong University, Jinan, Shandong Province, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lymphatic malformations (LMs) are common low-flow vascular anomalies in children. Macrocystic LMs are particularly prone to haemorrhage and may result in life-threatening airway compression. This report describes a 2-month-old female infant with a mixed lymphatic malformation involving the maxillofacial and cervical regions complicated by acute intracystic haemorrhage and severe dyspnoea. Initial management at an external institution simple cyst aspiration without sclerotherapy, which led to rapid disease progression. The patient subsequently underwent emergency sclerotherapy with pingyangmycin (PYM, also known as bleomycin A5) under combined ultrasound and digital subtraction angiography guidance, followed by prolonged oral sirolimus therapy for 2 years. Over a 7-year follow-up period, the lesions demonstrated a durable response without significant recurrence. This case highlights that single session interventional sclerotherapy combined with adjunctive sirolimus therapy can achieve excellent long term outcomes in infants with life-threatening mixed LMs. These findings provide valuable information for the clinical management of this severe condition.

Indexed as

haemorrhagiclong follow-uplymphatic malformationpediatricsclerotherapy

Identifiers

PMID42290712
PMCPMC13260515

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.